Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: SD NONMETROPOLITAN AREA — September 2026
Nonmetro SD clinical pay surges as regulatory work shifts elsewhere.
Clinical Research Associate advertised pay hit $114,430 in nonmetro South Dakota versus $90,956 nationally, even as Regulatory Affairs Specialist pay fell to $81,143 against a stable $104,000 national median.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- SD statewide unemployment: 2.0%-2.1% — vs 4.1% national rate, Sept 2026
- Labor force participation: 66.5% — Down 1.7 pts YoY; 7th highest nationally
- SD private-sector jobs: -900 (Aug) — vs +162,000 US nonfarm payrolls
- CRA advertised pay premium: $114,430 metro — vs $90,956 national median
Key takeaways
Declining nonmetro pay for regulatory roles may mask outsourcing, not weakness.
Regulatory Affairs Specialist advertised pay fell to $81,143 locally versus a stable $104,000 nationally, a wide enough gap to suggest complex regulatory work is increasingly handled by national firms or CROs rather than local hires. Treat this spread as a build-vs-outsource signal, not evidence that regulatory talent has gotten cheaper to retain.
Clinical research pay is pulling sharply ahead of national rates.
Clinical Research Associate advertised pay reached $114,430 locally against a $90,956 national median, a premium that is hard to explain through cost of living alone. Current conditions suggest real local scarcity in clinical operations talent, likely compounded by the region's shrinking labor force participation.
Biostatistician pay divergence signals this skillset barely exists locally.
Local Biostatistician pay sits at $74,360 against a national median of $133,322 — nearly half. This gap is consistent with a near-total absence of a resident biostatistics labor pool, reinforcing that statistical and data-heavy clinical functions are strong candidates for remote hiring or CRO partnership rather than local build-out.
Quality leadership hiring shows capital commitment despite soft headline jobs numbers.
Novartis's advertised VP Quality Assurance role at $275K-$310K, requiring 15+ years of biotech/pharma experience, stands out against a state that lost 900 private-sector jobs in August. Senior quality and scientific hiring appears insulated from broader nonmetro labor softening, reflecting committed manufacturing or development investment rather than headcount caution.
Median advertised pay by role — SD NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $135,141 | $135,141 | Significant increase | $131,354 |
| Clinical Research Associate | $70,714 | $114,430 | $119,546 | Significant increase | $90,956 |
| Lab Technician | $38,403 | $48,830 | $50,921 | Significant increase | $47,402 |
| Regulatory Affairs Specialist * | $75,529 | $81,143 | $89,023 | Moderate decline | $104,000 |
| Clinical Data Manager * | $99,344 | $111,806 | $114,422 | Significant decline | $123,031 |
| Biostatistician * | $58,356 | $74,360 | $108,363 | Significant decline | $133,322 |
| Validation Engineer | — | — | — | No data | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nonmetro South Dakota's labor market stays functionally tight — statewide unemployment sits near 2.0%-2.1% with labor force participation at 66.5%, down 1.7 points year-over-year, even as the state shed 900 private-sector jobs in August against a national gain of 162,000. For Life Sci employers outside Sioux Falls and Rapid City, this combination of scarce workers and softening headline job counts points to a market where hiring is constrained less by weak demand than by a shrinking pool of credentialed, mobile talent.
What it means
Falling participation alongside flat-to-declining advertised pay for roles like Regulatory Affairs Specialist and Biostatistician locally suggests employers are either filling specialized seats remotely or relying on CRO/CDMO partners rather than competing head-on for scarce nonmetro talent. Novartis's active recruiting for Principal Scientists and VP Quality Assurance signals that larger, capital-backed employers are still willing to pay premiums for senior scientific and quality leadership even as broader nonmetro hiring cools. Organizations should evaluate whether declining local advertised pay for regulatory and biostatistics roles reflects genuine market softening or a shift of that work toward outsourced or remote arrangements that nonmetro postings no longer capture.
Looking ahead
Worth watching: South Dakota's September BLS unemployment release lands October 20; a move off the 2.0%-2.1% range would be the first real signal of labor supply loosening in the nonmetro area this year.
Emerging pressure point: Labor force participation has fallen 1.7 points year-over-year even as unemployment stays near historic lows — watch whether this gap widens, which would tighten the credentialed talent pool further and sharpen build-vs-outsource tradeoffs.
Potential inflection point: Discovery District's 2,800-worker, 25-year life sciences buildout offers no near-term relief, but early hiring signals or facility announcements tied to it over the next two months would be the first concrete markers of future local supply.
Early indicator: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions; watch whether any released regulatory, quality or clinical talent shows interest in remote or relocation-based nonmetro roles, easing scarcity in CRA and quality hiring.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.